AHA 2021

Atrial Fibrillation

Updates on anti-arrhythmic agents

Presented By

Prof. John Camm, St George’s University of London, UK

Conference

EHRA 2022

1 June, 2022 10:59

New developments in remote diagnostics and monitoring of AF

Presented By

Dr Steven Lubitz, Massachusetts General Hospital, USA

Conference

AHA 2021

14 January, 2022 13:23

Head-to-head: Efficacy of dabigatran versus warfarin on cognitive impairment

Presented By

Prof. Bruno Caramelli, University of São Paulo, Brazil

Trial

Phase 4, GIRAF

Conference

AHA 2021

14 January, 2022 13:11

Posterior left pericardiotomy safe and effective in reducing atrial fibrillation

Presented By

Dr Mario Gaudino, Weill Cornell Medical Center, USA

Trial

PALACS

Conference

AHA 2021

14 January, 2022 13:05

LAA ligation did not reduce recurrent atrial arrhythmias in persistent AF

Presented By

Dr David Wilber, Loyola University Chicago, USA

Trial

aMAZE

Conference

AHA 2021

14 January, 2022 12:59

Equal benefits of early rhythm control in AF subtypes

Presented By

Dr Andreas Goette, St. Vincenz Hospital Paderborn, Germany

Trial

EAST-AFNET 4

Conference

AHA 2021

14 January, 2022 12:52

CVD Risk Reduction

Remote healthcare programme improves hypertension and lipid control

Presented By

Dr Alexander Blood, Brigham and Women’s Hospital, USA

Conference

AHA 2021

14 January, 2022 14:19

Novel oral PCSK9 inhibitor shows promising results for hypercholesterolaemia

Presented By

Dr Douglas Johns

Conference

AHA 2021

14 January, 2022 14:16

REVERSE-IT: Interim analysis shows promising effect of bentracimab on ticagrelor reversal

Presented By

Dr Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, REVERSE-IT

Conference

AHA 2021

14 January, 2022 14:12

No significant effect of aspirin on reducing cognitive impairment

Presented By

Prof. Jane Armitage, Oxford University, UK

Trial

ASCEND

Conference

AHA 2021

14 January, 2022 14:05

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By

Prof. Jeffrey Weitz, McMaster University, Canada

Trial

Phase 2, AXIOMATIC-TKR

Conference

AHA 2021

14 January, 2022 13:54

Network meta-analysis observes no clear effect of eicosapentaenoic acid on CV outcomes

Presented By

Dr Yujiro Yokoyama, St. Luke’s University Health Network, USA

Conference

AHA 2021

14 January, 2022 13:31

Heart Failure

Empagliflozin efficacious in HF patients with preserved ejection fractions ≥50%

Presented By

Dr Stefan Anker, Charité University Berlin, Germany

Trial

EMPEROR-Preserved

Conference

AHA 2021

14 January, 2022 15:15

EMPULSE: Empagliflozin improves outcomes of acute heart failure

Presented By

Prof. Adriaan Voors, University of Groningen, the Netherlands

Trial

Phase 3, EMPULSE

Conference

AHA 2021

14 January, 2022 15:03

CHIEF-HF: Canagliflozin improves health status in heart failure

Presented By

Prof. John Spertus, University of Missouri-Kansas City, USA

Trial

Phase 3, CHIEF-HF

Conference

AHA 2021

14 January, 2022 14:59

DREAM-HF: MPC therapy for HFrEF did not meet primary endpoint

Presented By

Dr Emerson Perin, Texas Heart Institute, US

Trial

Phase 3, DREAM-HF

Conference

AHA 2021

14 January, 2022 14:52

Therapeutic approaches in heart failure with diabetes

Presented By

Prof. Lynne Stevenson, Vanderbilt University Medical Center, USA

Conference

AHA 2021

14 January, 2022 14:48

Acute Coronary Syndrome

Vascular Diseases: PVD

Rivaroxaban regimen beneficial after revascularisation for claudication

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

VOYAGER PAD

Conference

AHA 2021

14 January, 2022 15:57

LIBERTY 360 shows quality-of-life improvements after peripheral vascular intervention

Presented By

Dr Mohsin Chowdhury, Harvard Medical School, USA

Trial

LIBERTY 360

Conference

AHA 2021

14 January, 2022 15:46

Deficient treatment outcomes after PVI in Black and low-income adults with PAD

Presented By

Dr Anna Krawisz, Beth Israel Deaconess Medical Center, MA, USA

Conference

AHA 2021

14 January, 2022 15:39

REDUCE-IT: Cardiovascular risk reduction with icosapent ethyl in PAD

Presented By

Dr Deepak Bhatt, Brigham and Women’s Hospital, Boston, USA

Trial

Phase 3, REDUCE-IT

Conference

AHA 2021

14 January, 2022 15:36

Vascular Diseases: CAD

Long-term reduced risk of CV events with ticagrelor plus aspirin after CABG

Presented By

Dr Qiang Zhao, Shanghai Jiao Tong University, China

Trial

DACAB-FE

Conference

AHA 2021

14 January, 2022 16:17

Early surgery outperforms conservative management in asymptomatic severe aortic stenosis

Presented By

Prof. Marko Banovic, University Clinical Centre of Serbia, Serbia

Trial

AVATAR

Conference

AHA 2021

14 January, 2022 16:11

External support device for SVG grafts in CABG surgery shows promise

Presented By

Prof. John Puskas, Mount Sinai Hospital, Israel

Trial

VEST Pivotal

Conference

AHA 2021

14 January, 2022 16:04

COVID-19 & the Heart

Other

2021 Guideline for Chest Pain: Top 10 takeaways

Presented By

Prof. Martha Gulati, University of Arizona, USA

Conference

AHA 2021

14 January, 2022 16:55

Accurate ejection fraction assessment in paediatric patients via artificial intelligence

Presented By

Dr Charitha Reddy, Stanford Children’s Health, USA

Conference

AHA 2021

14 January, 2022 16:49

Concomitant tricuspid annuloplasty reduces treatment failure in moderate tricuspid regurgitation

Presented By

Prof. James Gammie, University of Maryland, USA

Conference

AHA 2021

14 January, 2022 16:46